| NKTX Shares Outstanding History Table | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Below is a table of the NKTX shares outstanding history going back to 7/10/2020:
Also see: NKTX Market Cap History NKTX YTD Return |
NKTX Shares Outstanding History — Nkarta Share Count Over Time
As of 8/5/2026 Nkarta has 71.62 million NKTX shares outstanding. Investors often track the NKTX shares outstanding history to compare shareholder return trends against the change in share count over time.
This page shows NKTX share count trends over time, with 25 historical shares outstanding datapoints presented, dating back to 7/10/2020.
| NKTX Shares Outstanding History Chart | |||||||||||||||||||||||||||||||||||||||||||||||||||||
NKTX Historical Shares Outstanding: +17.84% CAGR 
Mouse over chart for data details
| |||||||||||||||||||||||||||||||||||||||||||||||||||||
| NKTX Stock Price Chart |
| About Nkarta Inc |
| Nkarta, Inc. is a clinical-stage biopharmaceutical company advancing the development of allogeneic, off-the-shelf engineered natural killer (NK) cell therapies for the treatment of patients with autoimmune diseases or hematologic malignancies. It is developing NKX019, a chimeric antigen receptor-natural killer (CAR NK) product candidate targeting the CD19 antigen and NKX101, a CAR NK product candidate targeting cells that display NKG2D ligands. Both product candidates enable an on-demand, off-the-shelf approach involving scaled manufacturing to broaden patient access. Its NKX019 autoimmune program is based on the potential to eliminate the pathologic B cells that produce autoantibodies. We show 25 historical shares outstanding datapoints in our coverage of NKTX's shares outstanding history. Understanding the changing numbers of NKTX shares outstanding — and comprehending the concept of differing number of shares outstanding in general comparing companies like NKTX versus peers — is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies. Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history. With this page we aim to empower investors researching NKTX by allowing them to research NKTX shares outstanding history as well as any other stock in our coverage universe. |
| NKTX Current Stock Quote |
Quotes delayed 20 minutes  Free NKTX Email Alerts:
Get Dividend Alerts 
Get SEC Filing Alerts
|
| Video: Shares Outstanding Importance | |
|
Video: Shares Outstanding Importance
| NKTX Share Performance |
| Shares Outstanding Peers |
| Nkarta (NKTX) is categorized under the Healthcare sector; to help you further research historical shares outstanding numbers, below are some other companies in the same sector:
NLNK Shares Outstanding History NLTX Shares Outstanding History NMRA Shares Outstanding History NMRD Shares Outstanding History NMTC Shares Outstanding History NMTR Shares Outstanding History NOTV Shares Outstanding History NOVN Shares Outstanding History NPCE Shares Outstanding History NRBO Shares Outstanding History More Healthcare companies » |
NKTX Shares Outstanding History | www.SharesOutstandingHistory.com | Copyright © 2017 - 2026, All Rights Reserved
Nothing in SharesOutstandingHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel
from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners.
None of the information contained herein constitutes a recommendation that any particular security, portfolio,
transaction, or investment strategy is suitable for any specific person. All viewers agree that under no
circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held
liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you
agree to the following Full Disclaimer & Terms of Use and
Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at
least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
